Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • Edoardo
    Junior Member
    • Mar 2016
    • 2

    #1

    Problem using SnpEff after Transdecoder: large number of warnings

    Hi,
    I am a PhD student with very little experience in bioinformatics (or very little experience at all, I started two months ago).
    I’m having some problems getting Snpeff to work with gff coordinates obtained by Transdecoder.
    I was given by a group with which I am collaborating the assembly of a genome and a gtf file with transcript information derived from RNAseq. I used Transdecoder following the instructions, with the –single_best_orf option, and I got the cds file and a gff3.
    I used the gff3 to build a database for snpeff, because I have to evaluate the effect of some SNPs on the genome. Howevere, when I launched Snpeff eff, I received a great number of warnings:

    INFO_REALIGN_3_PRIME 1
    WARNING_TRANSCRIPT_NO_START_CODON 202855
    WARNING_TRANSCRIPT_NO_START_CODON&INFO_REALIGN_3_PRIME 2
    WARNING_TRANSCRIPT_NO_STOP_CODON 17281

    Protein coding transcripts : 2426
    # Length errors : 0 ( 0,00% )
    # STOP codons in CDS errors : 0 ( 0,00% )
    # START codon errors : 686 ( 28,28% )
    # STOP codon warnings : 183 ( 7,54% )
    # UTR sequences : 2409 ( 99,30% )
    # Total Errors : 686 ( 28,28% )

    Given the low number of transcripts, this amount of warnings seems to be extremely high. Is it normal?
    Also, I checked the CDSs obtained by Transdecoder and, even if not all of them start with ATG, all of them have a start codon near the beginning of the sequence, so I really cannot explain this number of warnings.
    Do you have any suggestions?
    May the life of he/she who comes to my aid be filled with cakes and pizzas.
    Best Regards
    Edoardo

Latest Articles

Collapse

  • SEQadmin2
    Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
    by SEQadmin2


    Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

    The systematic characterization of the human proteome has
    ...
    07-20-2026, 11:48 AM
  • SEQadmin2
    Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
    by SEQadmin2



    Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
    ...
    07-09-2026, 11:10 AM
  • SEQadmin2
    Cancer Drug Resistance: The Lingering Barrier to Rising Survival
    by SEQadmin2



    Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

    There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
    07-08-2026, 05:17 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 07-24-2026, 12:17 PM
0 responses
10 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-23-2026, 11:41 AM
0 responses
11 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-20-2026, 11:10 AM
0 responses
23 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-13-2026, 10:26 AM
0 responses
37 views
0 reactions
Last Post SEQadmin2  
Working...